<DOC>
	<DOCNO>NCT02789436</DOCNO>
	<brief_summary>The purpose study determine whether Lactobacillus reuteri-containing lozenge ( Prodentis ) effective treatment halitosis patient chronic periodontitis .</brief_summary>
	<brief_title>Effect Probiotic Lozenges Halitosis Patients With Chronic Periodontitis</brief_title>
	<detailed_description>Bad breath ( oral malodor , lat . halitosis ) amongst common patient ' complaint dental office . Ironically , available literature research do topic thus far relatively scarce . Oral malodor commonly cause oral bacteria ( 87 % ) , yet also sourced ear , nose throat region small percentage distant part body unknown origin . Periodontal pathogen Gram ( - ) anaerobic microorganisms Porphyromonas gingivalis , Treponema denticola , Prevotella intermedia , Fusobacterium nucleatum , Enterobacter cloaca , Prevotella loescheii Porphyromonas endodontalis regard producer malodorous gas . Namely , bacterial specie periodontal pathogen particularly produce call volatile sulfur compound ( VSC ) give mouth air malodorness . Methylmercaptan , hydrogen sulfide dimethyl sulfide waste product bacterial metabolism , specifically degradation sulfur- , methionine- cysteine-containing aminoacids . Offensive smell also stem compound contain sulfur , diamines polyamines cadaverine , putrescine skatole . Probiotics define live microorganism consider beneficial health effect host consume adequate amount . Regarding advantageous role periodontal disease , inhibition specific periodontal pathogen alteration host immune response multifactorial cause think main working mechanism . Reuterin reutericyclin two bacteriocins produce Lactobacillus reuteri inhibit growth pathogenic bacteria , bacterium also exhibit strong capacity host tissue adherence subsequent competition pathogen . Based data , research efficacy probiotic lozenge halitosis patient chronic periodontitis .</detailed_description>
	<mesh_term>Periodontitis</mesh_term>
	<mesh_term>Chronic Periodontitis</mesh_term>
	<mesh_term>Halitosis</mesh_term>
	<criteria>Adult patient , age 30 Nonsmokers exsmokers ( smoke past year ) Moderate advance untreated chronic periodontitis Good compliance follow oral hygiene instruction Halitosis active phase patient 's subjective complaint Informed consent patient Exclusion Criteria Aggressive periodontitis Antibiotics administer 3 month prior study Pregnancy breastfeed Immunosuppressive therapy Oral neoplasm ( include radiation chemotherapy ) Diabetes mellitus Acute oral inflammation infection Poor , unsatisfactory oral hygiene lack compliance Use dietary supplement contain probiotic within 2 week prior study start</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>halitosis</keyword>
	<keyword>chronic periodontitis</keyword>
	<keyword>probiotic</keyword>
</DOC>